Start › Rak nerki (rak komórek nerkowych) › Missouri › St. Louis
Badania kliniczne dla Rak nerki (rak komórek nerkowych) w mieście St. Louis, MO
23 badań dla Rak nerki (rak komórek nerkowych) szuka uczestników w ośrodkach w mieście St. Louis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Washington University Medicine, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekrutacjaFaza 1
- Washington University School of Medicine, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- i 4 więcej
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekrutacjaFaza 1/2
- Washington University in St. Louis, St Louis
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekrutacjaFaza 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- i 5 więcej
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
RekrutacjaFaza 1/2
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekrutacjaBadanie obserwacyjne
- Washington University, St Louis
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
RekrutacjaFaza 3
- Washington University School of Medicine ( Site 0114), St Louis
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
RekrutacjaFaza 1/2
- Washington University School of Medicine, St Louis
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
RekrutacjaFaza 2
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekrutacjaFaza 1/2
- Washington University, St Louis
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RekrutacjaFaza 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi dalej
- i 1 więcej
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekrutacjaFaza 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- i 5 więcej
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekrutacjaFaza 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- i 6 więcej
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Research Site, St Louis
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
RekrutacjaFaza 1
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
RekrutacjaFaza 1
- Washington University School of Medicine, St Louis
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
RekrutacjaFaza 3
- Missouri Baptist Medical Center, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekrutacjaFaza 1
- Washington University School of Medicine, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
RekrutacjaFaza 2
- Siteman Cancer Center, Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekrutacjaFaza 1
- Washington University Medical Campus, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekrutacjaFaza 1/2
- Washington University, St Louis
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RekrutacjaFaza 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- i 4 więcej
Badania dla Rak nerki (rak komórek nerkowych) w innych miastach
- Houston, TX35 badań
- New York City, NY27 badań
- Nashville, TN23 badań
- Dallas, TX23 badań
- Los Angeles, CA20 badań
- Boston, MA16 badań
- Baldwin Park, CA16 badań
- Pittsburgh, PA15 badań
- Philadelphia, PA15 badań
- Queens, NY15 badań
- Jacksonville, FL14 badań
- Rochester, MN14 badań
Inne badania w mieście St. Louis
- Niedrobnokomórkowy rak płuca73 badań
- Rak piersi64 badań
- Nowotwór przerzutowy54 badań
- Rak jelita grubego i odbytnicy50 badań
- Nowotwory (wszystkie typy)46 badań
- Rak prostaty46 badań
- Rak płuc39 badań
- Rak jajnika38 badań
- Rak trzustki33 badań
- Rak endometrium29 badań
- Rak płaskonabłonkowy głowy i szyi28 badań
- Niewydolność serca26 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.